← biote Corp.
| Annual Trend | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Total Revenue | $139.4m |
$165.0m
+18.34%
|
$185.4m
+12.37%
|
$197.2m
+6.38%
|
$192.2m
-2.52%
|
|
| Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | $48.8m |
$54.6m
+11.80%
|
$57.9m
+6.05%
|
$58.1m
+0.44%
|
$54.9m
-5.63%
|
|
| Gross Profit | $90.6m |
$110.4m
+21.86%
|
$127.5m
+15.49%
|
$139.1m
+9.08%
|
$137.4m
-1.22%
|
|
| Selling, General and Administrative Expense | $49.1m | $165.5m | $98.8m | $107.5m | $101.8m | |
| Amortization of Intangible Assets | — | — | — | $1.2m | $1.2m | |
| Operating Income (Loss) | $34.6m |
($60.7m)
-275.70%
|
$28.7m
+147.19%
|
$31.6m
+10.31%
|
$35.6m
+12.46%
|
|
| Interest expense, net | ($1.7m) | ($5.1m) | ($6.4m) | ($11.0m) | ($11.0m) | |
| Fair Value, Option, Changes in Fair Value, Gain (Loss) | — | — | ($13.9m) | — | — | |
| Gain (loss) from change in fair value of earnout liabilities | — | $61.8m | ($9.0m) | ($19.6m) | $13.0m | |
| Other Nonoperating Income (Expense) | — | — | ($16k) | $11k | ($29k) | |
| Other income (expense), net | — | $29k | ($16k) | $11k | ($29k) | |
| Interest Income (Expense), Nonoperating, Net | ($1.7m) | ($5.1m) | ($6.4m) | ($11.0m) | ($11.0m) | |
| Total other income (expense), net | ($1.7m) | $62.4m | ($28.8m) | ($30.6m) | $2.0m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $33.2m | $2.2m | $300k | $1.3m | $38.0m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $32.9m | $1.7m | ($123k) | $1.0m | $37.6m | |
| Current Income Tax Expense (Benefit) | $286k | $1.1m | $2.0m | $3.9m | $2.0m | |
| Income Tax Expense (Benefit) | $286k | $388k | $2.7m | $970k | $6.0m | |
| Net Income (Loss) Attributable to Parent | $11.1m |
($969k)
-108.72%
|
$3.3m
+442.21%
|
$3.2m
-4.79%
|
$27.0m
+756.67%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | — | $2.3m | ($6.1m) | ($3.1m) | $4.6m | |
| Earnings Per Share, Basic | $0.66 | ($0.12) | $0.13 | $0.09 | $0.86 | |
| Earnings Per Share, Diluted | $0.64 | ($0.12) | $0.13 | $0.09 | $0.74 | |
| Weighted Average Number of Shares Outstanding, Basic | 34.1m | 8.1m | 25.7m | 34.3m | 31.3m | |
| Weighted Average Number of Shares Outstanding, Diluted | 34.3m | 8.1m | 25.7m | 34.3m | 36.7m | |
| Additional Financial Items | ||||||
| Capitalized Computer Software, Amortization | $687k | $1.0m | $2.2m | $1.6m | $1.2m | |
| Foreign currency translation adjustments | ($17k) | ($1k) | $8k | ($15k) | $6k | |
| Other comprehensive income (loss) | ($17k) | ($1k) | $8k | ($15k) | $6k | |
| Comprehensive income attributable to biote Corp. stockholders | $32.6m | $1.3m | ($2.8m) | $31k | $31.6m |